or Try an Advanced Search...

    Neos Stocks List

    Symbol Grade Name % Change
    NEO B NeoGenomics, Inc. -1.58
    JNJ D Johnson & Johnson -0.13
    BNDI D NEOS Enhanced Income Aggregate Bond ETF 0.00
    CSHI A NEOS Enhanced Income Cash Alternative ETF 0.02
    SPYI B NEOS S&P 500 High Income ETF 0.06
    View As Page of Charts
    Related Industries: Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Exchange Traded Funds SPDR Anatomical Pathology Antipsychotic Asset Backed Security Biology Bladder Cancer Blood Glucose Monitoring Bond Cancer Cardiovascular Disease Contact Lens Contact Lenses Counter Pharmaceutical Products Cytogenetics Diagnostic Products Disease Dow Jones Component Energy Products Fixed Income

    Related ETFs - A few ETFs which own one or more of the above listed Neos stocks.

    Symbol Grade Name Weight
    IHE D iShares U.S. Pharmaceutical ETF 22.5
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 6.97
    FLV A American Century Focused Large Cap Value ETF 6.89
    XLV C SPDR Select Sector Fund - Health Care 6.86
    IYH C iShares U.S. Healthcare ETF 6.64
    View all Neos ETFs...
    Compare ETFs
    Compare FTXH to FLV Compare FTXH to IYH Compare IHE to FTXH

        Neos Stocks Recent News

        Date Stock Title
        May 20 SPYI SPYI ETF: Prepare For The Return Of Volatility
        May 20 JNJ Johnson & Johnson's Tremfya meets goals in late-stage trial for ulcerative colitis
        May 20 JNJ Pulsed field ablation poised for fast adoption, analysts say
        May 20 JNJ J&J posts latest Varipulse data while awaiting FDA review
        May 19 JNJ Biopharma M&A surges year over year in Q1
        May 18 JNJ Novo Nordisk, J&J lead R&D rankings in big pharma: report
        May 18 JNJ Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
        May 18 JNJ Johnson & Johnson-backed Rapport Therapeutics files for $100M IPO
        May 17 JNJ Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution
        May 17 JNJ J&J-backed startup Rapport files for US IPO
        May 17 JNJ J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
        May 17 JNJ Dividend Roundup: Home Depot, Alibaba, Johnson & Johnson, Yum! Brands, and more
        May 16 JNJ Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
        May 16 JNJ Johnson & Johnson to Buy Proteologix For $850 Million in Cash
        May 16 JNJ Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
        May 16 JNJ Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors
        May 16 JNJ Johnson & Johnson to buy dermatology-focused biotech Proteologix
        May 16 JNJ UPDATE 1-Johnson & Johnson to acquire Proteologix for $850 million
        May 16 JNJ Johnson & Johnson to acquire Proteologix for $850 million
        May 16 JNJ Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
        Related Industries: Diagnostics & Research Drug Manufacturers - Major
        Related Stock Lists: Exchange Traded Funds SPDR Anatomical Pathology Antipsychotic Asset Backed Security Biology Bladder Cancer Blood Glucose Monitoring Bond Cancer Cardiovascular Disease Contact Lens Contact Lenses Counter Pharmaceutical Products Cytogenetics Diagnostic Products Disease Dow Jones Component Energy Products Fixed Income
        Neos

        Browse All Tags